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Abstract 
A total of 340 weaned pigs (Line 241 × 600, DNA; initially 11.2 lb BW) were used in a 45-d study to 
evaluate previous sow treatment (control vs. yeast additives) and nursery diets with or without added 
yeast-based pre- and probiotics (Phileo by Lesaffre, Milwaukee, WI) on antimicrobial resistance (AMR) 
patterns of fecal Escherichia coli. At placement in the nursery, pigs were housed by pen based on sow 
treatment and randomly assigned to 1 of 2 dietary treatments with 5 pigs per pen and 17 pens per 
treatment. Treatments were arranged in a 2 × 2 factorial with main effects of sow treatment (control vs. 
yeast-based pre- and probiotic diet; 0.10% ActiSaf Sc 47 HR+ and 0.025% SafMannan) and nursery 
treatment (control vs. yeast-based pre- and probiotic diet; 0.10% ActiSaf Sc 47 HR+, 0.05% SafMannan, 
and 0.05% NucleoSaf from d 0 to 7, then concentrations were lowered by 50% from d 7 to 24). All pigs 
were fed a common diet from d 24 to 45 post-weaning. The E. coli was isolated from fecal samples and 
species confirmation was accomplished by PCR detection of uidA and clpB genes. Microbroth dilution 
method (Sensititre CMV3AGNF panel plates) was used to determine the minimum inhibitory 
concentrations (MIC) of E. coli isolates to 14 different antimicrobials. Isolates were categorized as either 
susceptible, intermediate, or resistant based on Clinical and Laboratory Standards Institute guidelines. A 
three-way interaction of sow treatment × nursery treatment × sampling day was observed (P < 0.05) for 
ciprofloxacin, gentamicin, sulfisoxazole, and trimethoprim/ sulfamethoxazole. Fecal E. coli isolated from 
pigs of the yeast-supplemented sow group had increased (P = 0.034) MIC to nalidixic acid and a tendency 
for increased MIC to ciprofloxacin (P = 0.065) and gentamicin (P = 0.054). Yet, when yeast additives were 
fed in the nursery there was reduced (P < 0.05) fecal E. coli AMR to azithromycin and chloramphenicol. All 
fecal E. coli isolates were considered susceptible to all antimicrobials, except tetracycline on d 5. In 
conclusion, feeding sows live yeast and yeast extracts could potentially impact fecal E. coli AMR in their 
progeny. Furthermore, feeding live yeast and yeast additives in the nursery may alleviate the AMR of 
azithromycin and chloramphenicol of E. coli isolated from nursery pig fecal material. 
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Summary
A total of 340 weaned pigs (Line 241 × 600, DNA; initially 11.2 lb BW) were used 
in a 45-d study to evaluate previous sow treatment (control vs. yeast additives) and 
nursery diets with or without added yeast-based pre- and probiotics (Phileo by Lesaffre, 
Milwaukee, WI) on antimicrobial resistance (AMR) patterns of fecal Escherichia coli. 
At placement in the nursery, pigs were housed by pen based on sow treatment and 
randomly assigned to 1 of 2 dietary treatments with 5 pigs per pen and 17 pens per 
treatment. Treatments were arranged in a 2 × 2 factorial with main effects of sow 
treatment (control vs. yeast-based pre- and probiotic diet; 0.10% ActiSaf Sc 47 HR+ 
and 0.025% SafMannan) and nursery treatment (control vs. yeast-based pre- and 
probiotic diet; 0.10% ActiSaf Sc 47 HR+, 0.05% SafMannan, and 0.05% NucleoSaf 
from d 0 to 7, then concentrations were lowered by 50% from d 7 to 24). All pigs were 
fed a common diet from d 24 to 45 post-weaning. The E. coli was isolated from fecal 
samples and species confirmation was accomplished by PCR detection of uidA and 
clpB genes. Microbroth dilution method (Sensititre CMV3AGNF panel plates) was 
used to determine the minimum inhibitory concentrations (MIC) of E. coli isolates 
to 14 different antimicrobials. Isolates were categorized as either susceptible, inter-
mediate, or resistant based on Clinical and Laboratory Standards Institute guidelines. 
A three-way interaction of sow treatment × nursery treatment × sampling day was 
observed (P < 0.05) for ciprofloxacin, gentamicin, sulfisoxazole, and trimethoprim/
sulfamethoxazole. Fecal E. coli isolated from pigs of the yeast-supplemented sow group 
had increased (P = 0.034) MIC to nalidixic acid and a tendency for increased MIC to 
ciprofloxacin (P = 0.065) and gentamicin (P = 0.054). Yet, when yeast additives were 
fed in the nursery there was reduced (P < 0.05) fecal E. coli AMR to azithromycin and 
1  Department of Diagnostic Medicine/Pathology, College of Veterinary Medicine, Kansas State Univer-
sity.
2  Department of Clinical Sciences, College of Veterinary Medicine, Kansas State University.
3  Department of Statistics, College of Arts and Sciences, Kansas State University.
4  Phileo by Lesaffre, Milwaukee, WI.
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chloramphenicol. All fecal E. coli isolates were considered susceptible to all antimicro-
bials, except tetracycline on d 5. In conclusion, feeding sows live yeast and yeast extracts 
could potentially impact fecal E. coli AMR in their progeny. Furthermore, feeding live 
yeast and yeast additives in the nursery may alleviate the AMR of azithromycin and 
chloramphenicol of E. coli isolated from nursery pig fecal material. 
Introduction
Yeast-based pre- and probiotics have been considered a potential alternative to in-feed 
antibiotics and pharmacological levels of zinc in the nursery because of their ability to 
positively modulate gut microflora, which may lead to improved immunity, nutrient 
digestion and absorption, and growth performance.5 This report is a companion to our 
previous study where we evaluated the effects of the live yeast Saccharomyces cerevisiae 
strain NCYC Sc 47 and yeast-based prebiotics derived from Saccharomyces cerevisiae on 
nursery pigs weaned from sows fed a diet with or without yeast additives on weanling 
pig growth performance.6 The objective of this study was to evaluate effects of the live 
yeast Saccharomyces cerevisiae strain NCYC Sc 47 and yeast-based prebiotics derived 
from Saccharomyces cerevisiae on nursery pigs weaned from sows fed a diet with or 




The Kansas State University Institutional Animal Care and Use Committee approved 
the protocol used in this experiment. The study was conducted at the Kansas State 
University Swine Teaching and Research Center in Manhattan, KS. The facility is 
completely enclosed, environmentally controlled, and mechanically ventilated. Each 
pen contained a 4-hole, dry self-feeder and a nipple waterer to provide ad libitum access 
to feed and water. Pens (4 × 4 ft) had metal tri-bar floors and allowed approximately 
2.7 ft2/pig. 
Animals and treatment structure
A total of 340 weaned pigs (DNA 241 × 600, DNA; initially 11.2 ± 0.07 lb BW), 
offspring of sows fed either a control diet or a diet containing yeast-based pre- and 
probiotics from d 110 of gestation through weaning, were used in a 45-d nursery study 
with 5 pigs per pen and 17 pens (replications) per treatment. Details regarding pig allot-
ment, experimental design, and diet preparation can be found in Chance et al.6
Briefly, dietary treatments were arranged in a 2 × 2 factorial with sow treatment 
(control vs. yeast additives; 0.10% ActiSaf Sc 47 HR+ and 0.025% SafMannan; Phileo 
by Lesaffre, Milwaukee, WI) and nursery treatment (control vs. yeast additives; 0.10% 
ActiSaf Sc 47 HR+, 0.05% SafMannan, and 0.05% NucleoSaf from d 0 to 7 then 
concentrations were lowered by 50% from d 7 to 24; Phileo by Lesaffre, Milwaukee, 
5  Menegat, M. B., R. D. Goodband, J. M. DeRouchey, M. D. Tokach, J. C. Woodworth, and S. S. Dritz. 
2019. Kansas State University Swine Nutrition Guide: Feed Additives in Swine Diets.
6  Chance, J. A., J. T. Gebhardt, J. M. DeRouchey, M. D. Tokach, J. C. Woodworth, R. D. Goodband, 
and J. A. Loughmiller. 2021. The Effect of Live Yeast and Yeast Extracts on Growth Performance of 
Nursery Pigs Weaned from Sows Fed Diets with or without Yeast Additives. Kansas Experimental 
Station Research Reports: Vol. 7, Issue 11.
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WI). Thus, half of the pigs from each sow group was fed either a control diet or a diet 
with yeast additives. The live yeast Saccharomyces cerevisiae strain NCYC Sc 47 (ActiSaf 
Sc 47 HR+) served as the yeast-based probiotic. The yeast-based prebiotics included a 
yeast cell wall fraction with concentrated mannan-oligosaccharides and β-glucans from 
Saccharomyces cerevisiae (SafMannan) and a yeast extract containing ≥ 6% unbound 
nucleotides from Saccharomyces cerevisiae (NucleoSaf). 
Fecal collection
Fecal samples were collected on d 5, 24, and 45 of the experiment for antimicrobial 
resistance profiles of fecal E. coli. Fecal samples were collected directly from the rectum 
of the same three randomly selected pigs from each pen and pooled by pen to form one 
composite sample. Fecal samples were collected using a sterile, single-use cotton tipped 
applicator (Fisher Healthcare, Pittsburgh, PA) and were stored in a clean, single-use 
zipper storage bag and kept on ice until delivered to the laboratory on the same day 
of collection. Fecal samples were transported to the laboratory of Dr. Raghavendra 
Amachawadi at the Kansas State University College of Veterinary Medicine for bacte-
rial isolation and antimicrobial susceptibility testing.
E. coli isolation
Approximately 1 g of fecal sample was suspended in 9 mL of phosphate-buffered saline. 
Fifty microliters of the fecal suspension were then spread-plated onto a MacConkey 
agar (Becton Dickinson, Sparks, MD) for the isolation of E. coli. Two lactose-fer-
menting colonies were picked from each MacConkey agar; each colony was individually 
streaked onto a blood agar plate (Remel, Lenexa, KS) and incubated at 98.6°F for 24 h. 
An indole test was conducted and indole-positive isolates were stored in cryo-protect 
beads (Cryocare, Key Scientific Products, Round Rock, TX) at -112°F. Species confir-
mation of E. coli was by polymerase chain reaction (PCR) assay for uidA and clpB genes.
Antimicrobial susceptibility testing of E. coli isolates
Antimicrobial susceptibility testing was done on E. coli isolates recovered on days 5, 
24, and 45. The microbroth dilution method as outlined by the Clinical and Labora-
tory Standards Institute (CLSI, 2018)7 was used to determine the minimal inhibitory 
concentrations (MIC) of antibiotics. The antimicrobials evaluated included: amoxi-
cillin/clavulanic acid 2:1 ratio, ampicillin, azithromycin, cefoxitin, ceftiofur, ceftriaxone, 
chloramphenicol, ciprofloxacin, gentamicin, nalidixic acid, streptomycin, sulfisoxazole, 
tetracycline, and trimethoprim/sulfamethoxazole. Each isolate, stored in cryo-protect 
beads, was streaked onto a blood agar plate and incubated at 98.6°F for 24 h. Individual 
colonies were suspended in demineralized water (Trek Diagnostic Systems, Cleveland, 
OH) and turbidity was adjusted to 0.5 McFarland turbidity standards. Then, 10 µL of 
the bacterial inoculum was added to Mueller–Hinton broth and vortexed to mix. A 
Sensititre automated inoculation delivery system (Trek Diagnostics Systems) was used 
to dispense 100 µL of the culture into National Antimicrobial Resistance Monitoring 
System (NARMS) panel plates designed for Gram-negative (CMV3AGNF, Trek 
Diagnostic Systems) bacteria. Escherichia coli ATCC 25922 (American Type Culture 
Collection, Manassas, VA) strains were included as quality controls for E. coli suscepti-
bility testing. Plates were incubated at 98.6°F for 18 h and bacterial growth was assessed 
7 Clinical and Laboratory Standards Institute (CLSI). 2018. Performance standards for antimicrobial 
disk and dilution susceptibility tests for bacteria isolated from animals. Approved standard, 5th ed. CLSI 
supplement VET08. CLSI, Wayne, PA.
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using Sensititre ARIS and Vizion systems (Trek Diagnostic Systems). Clinical and 
Laboratory Standards Institute (CLSI, 2018; Table 1) guidelines were used to classify 
each isolate as susceptible, intermediate, or resistant according to the breakpoints estab-
lished for each antimicrobial. The MIC values greater than the susceptible breakpoint 
but lower than the resistant breakpoint were considered intermediate.
Statistical analysis
The MIC data of each antimicrobial were analyzed using a linear mixed model. Fixed 
effects of the model included sow diet, nursery pig diet, sampling day, and their second- 
and third-order interactions. Pen was included in the model as a random effect. The 
variance-covariance structure of pen was taken as either compound symmetry, first-
order autoregressive or unstructured according to the model fitting criteria. To better 
satisfy model assumptions, data underwent natural log transformation before statistical 
modeling. Treatment effect was assessed via back-transformed least squares means, the 
geometric means of the MIC values. Statistical analysis was performed using SAS (v. 
9.4, SAS Inst.; Cary, NC) PROC MIXED with option DDFM=KR in the MODEL 
statement. Differences between treatments were considered significant at P ≤ 0.05 and 
marginally significant at 0.05 < P ≤ 0.10.
Results and Discussion
A three-way interaction of sow treatment × nursery treatment × sampling day was 
observed (P < 0.05) for ciprofloxacin, gentamicin, sulfisoxazole, and trimethoprim/
sulfamethoxazole (Table 2). E. coli isolated from feces of pigs from sows fed yeast 
additives and fed yeast-based pre- and probiotics through the nursery had reduced 
(P = 0.044) MIC values to ciprofloxacin on d 45 with a tendency (P = 0.081) for 
reduced AMR on d 24 compared to pigs from the same sow treatment group but fed a 
control nursery diet. However, there was evidence for a marginal increase (P = 0.061) 
in MIC values of E. coli to ciprofloxacin on d 5 from progeny of sows fed yeast which 
were also fed live yeast and yeast extracts in the nursery. For gentamicin, MIC values 
of fecal E. coli isolated from pigs of the yeast-fed sow and yeast nursery treatment were 
higher (P = 0.021) on d 5 but lower (P = 0.018) on d 24 compared to the yeast sow and 
control nursery treatment. On d 45, E. coli isolated from feces collected from progeny 
of the control sows that were then fed yeast-based pre- and probiotics in the nursery 
had lower (P = 0.005) MIC values to sulfisoxazole compared to pigs that were also 
from the control sow group but fed a control diet in the nursery. Fecal E. coli had lower 
(P = 0.004) MIC values on d 5 to trimethoprim/sulfamethoxazole from the control 
sow and yeast nursery treatment compared to the control sow and control nursery 
treatment. It is important to note that all fecal E. coli isolates had a low MIC values for 
ciprofloxacin, gentamicin, sulfisoxazole, and trimethoprim/sulfamethoxazole and thus, 
all values would be classified as susceptible for each respective antimicrobial. There were 
no further three- or two-way interactions observed; thus, the main effects of sow treat-
ment, nursery treatment, and sampling day were explored (Table 3). 
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For the sow portion of this study, regardless of dietary treatment, sow fecal E. coli had 
increased (P < 0.001) AMR to tetracycline at weaning compared to AMR at the entry 
into the farrowing house.8 Interestingly, this effect carried over into the nursery. All 
fecal E. coli isolates had significantly (P < 0.001) higher MIC values to tetracycline on d 
5 post-weaning, which then decreased on d 24 and then slightly increased on d 45. No 
matter the dietary treatment combination, all E. coli isolated were resistant to tetracy-
cline on d 5 but were intermediate on d 24 and 45. Fecal E. coli isolates were considered 
susceptible or intermediate for the remaining 13 antimicrobials at all three sampling 
timepoints (d 5, 24, and 45) regardless of the sow or nursery treatment’s inclusion of 
live yeast and yeast extracts. 
E. coli isolated from feces of the progeny of sows fed yeast-based pre- and probiotics 
had increased (P = 0.034) MIC values to nalidixic acid and a tendency for increased 
AMR to ciprofloxacin (P = 0.065) and gentamicin (P = 0.054). Fecal E. coli isolates had 
reduced AMR to azithromycin (P = 0.037) and chloramphenicol (P = 0.031) when live 
yeast and yeast extracts were supplemented in the nursery. Again, all fecal E. coli isolates 
would be classified as susceptible or intermediate for each respective antimicrobial as 
tetracycline was the only antibiotic that displayed resistance in this study. 
There was evidence for decreased (P < 0.05) AMR over time in fecal E. coli for azith-
romycin, cefoxitin, and streptomycin regardless of yeast-based pre- and probiotic 
supplementation in the sow or nursery treatment. Axomicillin:clavulanic acid 2:1 ratio, 
chloramphenicol, and trimethoprim/sulfamethoxazole had increased (P < 0.10) MIC 
values from d 5 to 24 and then reduced MIC values from d 24 to 45. This differs from 
gentamicin, nalidixic acid, and tetracycline which had reduced (P < 0.10) AMR from d 
5 to 24 and then an increase in MIC values from d 24 to 45.  
In conclusion, progeny from sows that were fed yeast-based pre- and probiotics had 
increased potential of fecal E. coli AMR to nalidixic acid, ciprofloxacin, and gentamicin. 
Yet, feeding live yeast and yeast extracts in the nursery reduced the AMR of azithro-
mycin and chloramphenicol of fecal E. coli. Interestingly, fecal E. coli samples isolated 
from all the weaned pigs were resistant to tetracycline with MIC values decreasing 
over time. In the sow portion of this study, regardless of dietary treatment, fecal 
E. coli isolated from sows had a significant increase in AMR to tetracycline at weaning 
compared to entry into the farrowing house. It is important to reiterate that all fecal 
E. coli isolates were considered susceptible or intermediate to the remaining 13 antimi-
crobials based on CLSI (2018) guidelines. 
Brand names appearing in this publication are for product identification purposes only. 
No endorsement is intended, nor is criticism implied of similar products not mentioned. 
Persons using such products assume responsibility for their use in accordance with current 
label directions of the manufacturer.
8  Chance, J. A., J. T. Gebhardt, J. M. DeRouchey, R. G. Amachawadi, V. Ishengoma, T. G. Nagaraja, M. 
D. Tokach, J. C. Woodworth, R. D. Goodband, Q. Kang, and J. A. Loughmiller. 2021. The Effect of Live 
Yeast and Yeast Extracts on Sow and Litter Performance and Sow Antimicrobial Susceptibility of Fecal 
Escherichia coli. Kansas Experimental Station Research Reports: Vol. 7, Issue 11.
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Table 1. Resistance breakpoints and evaluated concentrations for antimicrobials of National Antimi-











Amoxicillin:clavulanic acid 2:1 
ratio
Critically important ≤ 8/4 16/8 ≥ 32/16
Ampicillin Critically important ≤ 8 16 ≥ 32
Azithromycin Critically important ≤ 16 N/A3 ≥ 32
Cefoxitin Highly important ≤ 8 16 ≥ 32
Ceftiofur Critically important ≤ 2 4 ≥ 8
Ceftriaxone Critically important ≤ 1 2 ≥ 4
Chloramphenicol Highly important ≤ 8 16 ≥ 32
Ciprofloxacin Critically important ≤ 0.06 ≥ 0.12 ≥ 0.12
Gentamicin Critically important ≤ 4 8 ≥ 16
Nalidixic acid Critically important ≤ 16 N/A ≥ 32
Streptomycin Critically important ≤ 16 N/A ≥ 32
Sulfisoxazole Highly important ≤ 256 N/A ≥ 512
Tetracycline Highly important ≤ 4 8 ≥ 16
Trimethoprim/sulfamethoxazole 
1:19 ratio
Highly important ≤ 2/38 N/A ≥ 4/76
1 Breakpoints established by Clinical and Laboratory Standards Institute (Clinical and Laboratory Standards Institute (CLSI). 2018. 
Performance standards for antimicrobial disk and dilution susceptibility tests for bacteria isolated from animals. Approved standards 
(5th ed. CLSI supplement VET08. CLSI, Wayne, PA), which are categorized as susceptible (treatable), intermediate (possibly treat-
able with higher doses), and resistant (not treatable). Minimal inhibitory concentration (MIC) values greater than the susceptible 
breakpoint but lower than the resistant breakpoint were considered intermediate.
2 World Health Organization (WHO) categorization of antimicrobials according to importance for human medicine (WHO, 
2018).
3N/A = not applicable. The National Antimicrobial Resistance Monitoring System has not established breakpoints; therefore, there 














































































Table 2. Effects of sow and nursery pig dietary treatment over time on antimicrobial susceptibilities of fecal Escherichia coli according to National Antimi-
crobial Resistance Monitoring System (CLSI, 2018) established breakpoints1,2
Sow treatment:3 Control Yeast P =
Nursery 










Amoxicillin:clavulanic acid 2:1 ratio5 0.455 0.389 0.024 0.389 0.438 0.656 0.849
d 5 4.9 ± 1.1 5.1 ± 1.1 6.3 ± 1.3 6.0 ± 1.3
d 24 6.8 ± 1.5 8.0 ± 1.7 10.2 ± 2.2 8.0 ± 1.7
d 45 6.8 ± 1.5 5.5 ± 1.2 6.3 ± 1.3 4.5 ± 1.0
Ampicillin 0.925 0.85 0.191 0.220 0.697 0.226 0.856
d 5 7.7 ± 2.2 9.0 ± 2.5 7.7 ± 2.2 7.4 ± 2.1
d 24 7.4 ± 2.1 11.1 ± 3.1 10.2 ± 2.9 12.0 ± 3.4
d 45 7.7 ± 2.2 6.8 ± 1.9 9.0 ± 2.5 4.3 ± 1.2
Azithromycin 0.291 0.037 0.034 0.480 0.484 0.909 0.328
d 5 5.1 ± 0.46 5.1 ± 0.46 5.3 ± 0.48 4.5 ± 0.41
d 24 4.5 ± 0.32 4.0 ± 0.28 4.5 ± 0.32 4.5 ± 0.32
d 45 4.2 ± 0.24 4.0 ± 0.23 4.9 ± 0.28 4.2 ± 0.24
Cefoxitin 0.434 0.372 0.006 0.823 0.352 0.543 0.781
d 5 10.2 ± 2.0 8.3 ± 1.6 9.4 ± 1.8 9.8 ± 1.9
d 24 8.0 ± 1.5 8.0 ± 1.5 10.6 ± 2.1 11.1 ± 2.1
d 45 7.4 ± 1.4 6.0 ± 1.2 7.4 ± 1.4 5.3 ± 1.0
Ceftiofur 0.438 0.877 0.962 0.485 0.708 0.374 0.073
d 5 0.96 ± 0.30 0.64 ± 0.20 0.69 ± 0.22 1.70 ± 0.53
d 24 0.92 ± 0.29 0.88 ± 0.28 0.96 ± 0.30 1.08 ± 0.34
d 45 0.92 ± 0.29 0.92 ± 0.29 1.28 ± 0.40 0.61 ± 0.19
Ceftriaxone 0.687 0.762 0.279 0.481 0.194 0.519 0.509
d 5 0.42 ± 0.19 0.48 ± 0.21 0.82 ± 0.36 1.13 ± 0.50
d 24 1.04 ± 0.46 1.13 ± 0.50 0.96 ± 0.43 0.88 ± 0.39















































































Table 2. Effects of sow and nursery pig dietary treatment over time on antimicrobial susceptibilities of fecal Escherichia coli according to National Antimi-
crobial Resistance Monitoring System (CLSI, 2018) established breakpoints1,2
Sow treatment:3 Control Yeast P =
Nursery 










Chloramphenicol 0.299 0.031 <0.001 0.136 0.966 0.180 0.701
d 5 9.0 ± 0.97 7.1 ± 0.76 9.0 ± 0.97 6.5 ± 0.70
d 24 9.4 ± 1.01 11.1 ± 1.19 10.2 ± 1.09 8.7 ± 0.93
d 45 7.4 ± 0.79 7.1 ± 0.76 7.4 ± 0.79 6.3 ± 0.67              
Ciprofloxacin6 0.065 0.557 0.790 0.291 0.419 0.495 0.010
























Gentamicin7 0.054 0.638 < 0.001 0.736 0.379 0.065 0.045
d 5 0.96 ± 0.210 0.89 ± 0.194 0.96 ± 0.210 2.00 ± 0.437
d 24 0.48 ± 0.086 0.48 ± 0.086 0.72 ± 0.129 0.39 ± 0.070
d 45 0.72 ± 0.071 0.61 ± 0.060 0.78 ± 0.077 0.67 ± 0.065
Nalidixic acid 0.034 0.648 0.075 0.648 0.061 0.551 0.201
d 5 2.0 ± 0.45 2.0 ± 0.45 3.1 ± 0.71 4.2 ± 0.94
d 24 2.2 ± 0.13 2.1 ± 0.13 2.4 ± 0.15 2.1 ± 0.13
d 45 2.2 ± 0.35 3.0 ± 0.49 2.9 ± 0.47 2.5 ± 0.40
Streptomycin 0.493 0.600 < 0.001 0.444 0.147 0.391 0.393
d 5 14.2 ± 3.23 21.3 ± 4.86 13.1 ± 2.98 16.0 ± 3.65
d 24 7.1 ± 2.56 12.5 ± 4.53 11.6 ± 4.17 8.3 ± 3.01















































































Table 2. Effects of sow and nursery pig dietary treatment over time on antimicrobial susceptibilities of fecal Escherichia coli according to National Antimi-
crobial Resistance Monitoring System (CLSI, 2018) established breakpoints1,2
Sow treatment:3 Control Yeast P =
Nursery 










Sulfisoxazole8 0.881 1.000 0.363 0.159 0.989 0.416 0.035
d 5 67 ± 20 78 ± 24 69 ± 21 85 ± 26
d 24 48 ± 15 64 ± 20 57 ± 17 57 ± 17
d 45 109 ± 33 32 ± 10 44 ± 14 78 ± 24
Tetracycline 0.540 0.624 < 0.001 0.223 0.580 0.985 0.645
d 5 25.1 ± 3.7 30.7 ± 4.5 26.1 ± 3.9 18.8 ± 2.8
d 24 6.8 ± 1.5 7.4 ± 1.7 8.3 ± 1.9 6.5 ± 1.5
d 45 8.7 ± 2.1 8.3 ± 2.0 8.3 ± 2.0 8.3 ± 2.0
Trimethoprim/sulfamethoxazole5,9 0.781 0.304 0.069 0.973 0.415 0.208 0.042
d 5 0.42 ± 0.126 0.12 ± 0.036 0.24 ± 0.074 0.24 ± 0.074
d 24 0.28 ± 0.083 0.37 ± 0.111 0.30 ± 0.091 0.21 ± 0.063
d 45 0.12 ± 0.036 0.18 ± 0.055 0.22 ± 0.068 0.18 ± 0.055              
1A total of 340 pigs (initially 11.0 or 11.5 ± 0.07 lb) were used in a 45-d nursery trial with 5 pigs per pen and 17 pens per treatment. Pigs were weaned at approximately19 d of age and allotted to treatment 
in completely randomized design. Dietary treatments were arranged in a 2 × 2 factorial with sow treatment (control or yeast-based probiotics) and nursery pig treatment (control or yeast-based probiotics). 
Data were reported as geometric mean of minimal inhibitory concentration (MIC) ± standard error of the mean.
 2Fecal samples from the same 3 pigs/pen were collected on d 5, 24, and 45.
3Sow treatment consisted of providing a control diet or a yeast-based pre- and probiotic diet supplemented with ActiSaf Sc 47 HR+ at 0.10% and SafMannan at 0.03% (Phileo by Lesaffre, Milwaukee, WI) 
from d 110 of gestation until weaning. Sow fecal samples were collected on ~ d 110 of gestation and d 18 post-farrowing.
 4Nursery treatment consisted of providing a control diet or a yeast-based pre- and probiotic diet supplemented with 0.10% ActiSaf Sc 47 HR+, 0.05% SafMannan, and 0.05% NucleoSaf in phase 1 diets 
and then concentrations were lowered by 50% in phase 2 diets (Phileo by Lesaffre, Milwaukee, WI).
 5The MIC numerator of the ratio was reported for the antimicrobial’s amoxicillin:clavulanic acid 2:1 ratio and trimethoprim/sulfamethoxazole 1:19 ratio.
6A three-way interaction of sow treatment × nursery treatment × day was observed (P = 0.010). On d 24 (P = 0.081) and on d 45 (P = 0.045), pigs that were fed yeast in the nursery and came from the yeast 
sow group had reduced MIC values compared to nursery pigs fed a control diet who were also reared from sows fed yeast. There was marginal evidence on d 5 (P = 0.061) for the yeast sow group offspring 
fed yeast additives having increased MIC values compared to pigs fed a control diet who were also offspring of sows fed yeast.
7A three-way interaction of sow treatment × nursery treatment × day was observed (P = 0.045). The MIC values of fecal E. coli isolated from pigs of the yeast sow and yeast nursery treatment were higher (P 
= 0.021) on d 5 but lower (P = 0.018) on d 24 compared to the yeast sow and control nursery treatment. There was no evidence for difference (P > 0.10) between dietary treatments on d 45.
8Three-way interaction of sow treatment × nursery treatment × day was observed (P = 0.035). On d 45, pigs that came from the control sow treatment and yeast nursery treatment had lower (P = 0.005) 
MIC values compared to pigs that were also from the control sow group but fed a control diet in the nursery. There was no evidence for difference (P > 0.10) between dietary treatments on d 5 or d 24.
9Three-way interaction of sow treatment × nursery treatment × day was observed (P = 0.042). On d 5, pigs that came from the control sow treatment and yeast nursery treatment had lower (P = 0.004) 














































































Table 3. Main effects of sow and nursery pig dietary treatment over time on antimicrobial susceptibilities of fecal Escherichia coli according to National Anti-







P =Control Yeast Control Yeast 5 24 45
Amoxicillin:clavulanic 
acid 2:1 ratio5
6.1 ± 0.51 6.7 ± 0.55 0.455 6.7 ± 0.56 6.1 ± 0.50 0.389 5.5 ± 0.59a 8.2 ± 0.87b 5.7 ± 0.61a 0.024
Ampicillin 8.2 ± 0.83 8.1 ± 0.82 0.925 8.2 ± 0.83 8.0 ± 0.81 0.850 7.9 ± 1.1 10.0 ± 1.4 6.7 ± 0.9 0.191
Azithromycin 4.5 ± 0.12 4.7 ± 0.13 0.291 4.7 ± 0.13 4.4 ± 0.12 0.037 5.0 ± 0.23b 4.4 ± 0.16a 4.3 ± 0.12a 0.034
Cefoxitin 7.9 ± 0.67 8.7 ± 0.74 0.434 8.7 ± 0.75 7.8 ± 0.67 0.372 9.4 ± 0.91b 9.3 ± 0.90b 6.5 ± 0.62a 0.006
Ceftiofur 0.87 ± 0.11 0.99 ± 0.12 0.438 0.94 ± 0.12 0.92 ± 0.11 0.877 0.92 ± 0.14 0.96 ± 0.15 0.90 ± 0.14 0.962
Ceftriaxone 0.71 ± 0.14 0.79 ± 0.15 0.687 0.78 ± 0.15 0.72 ± 0.14 0.762 0.66 ± 0.15 1.00 ± 0.22 0.65 ± 0.14 0.279
Chloramphenicol 8.4 ± 0.35 7.9 ± 0.33 0.299 8.7 ± 0.36 7.6 ± 0.32 0.031 7.8 ± 0.42a 9.8 ± 0.52b 7.0 ± 0.37a < 0.001















Gentamicin 0.67 ± 0.047 0.81 ± 0.058 0.054 0.75 ± 0.053 0.72 ± 0.051 0.638 1.13 ± 0.124c 0.51 ± 0.045a 0.69 ± 0.034b < 0.001
Nalidixic acid 2.2 ± 0.16 2.8 ± 0.20 0.034 2.4 ± 0.18 2.5 ± 0.19 0.648 2.7 ± 0.30b 2.2 ± 0.07a 2.6 ± 0.21b 0.075
Streptomycin 9.7 ± 1.1 10.9 ± 1.3 0.493 9.8 ± 1.2 10.7 ± 1.3 0.600 15.8 ± 1.8b 9.6 ± 1.7a 7.1 ± 0.9a < 0.001
Sulfisoxazole 61.9 ± 7.9 63.6 ± 8.1 0.881 62.7 ± 8.0 62.7 ± 8.0 1.000 74.6 ± 11.4 56.1 ± 8.6 59.0 ± 9.0 0.363
Tetracycline 11.9 ± 0.93 11.1 ± 0.87 0.540 11.8 ± 0.92 11.2 ± 0.87 0.624 24.8 ± 1.83b 7.2 ± 0.82a 8.4 ± 1.03a < 0.001
Trimethoprim/
Sulfamethoxazole5 0.22 ± 0.028 0.23 ± 0.029 0.781 0.25 ± 0.031 0.20 ± 0.026 0.304 0.23 ± 0.035b 0.28 ± 0.043b 0.17 ± 0.026a 0.069
1A total of 340 pigs (initially 11.0 or 11.5 ± 0.07 lb) were used in a 45-d nursery trial with 5 pigs per pen and 17 pens per treatment. Pigs were weaned at approximately 19 d of age and allotted to treatment 
in completely randomized design. Dietary treatments were arranged in a 2 × 2 factorial with main effects of sow treatment (control or yeast-based probiotics) and nursery pig treatment (control or yeast-
based probiotics). Data reported as geometric mean of minimal inhibitory concentration (MIC) ± standard error of the mean.
2Fecal samples from the same 3 pigs/pen were collected on d 5, 24, and 45. Sow fecal samples were collected on ~ d 110 of gestation and d 18 post-farrowing.
3Sow treatment consisted of providing a control diet or a yeast-based pre- and probiotic diet supplemented with ActiSaf Sc 47 HR+ at 0.10% and SafMannan at 0.03% (Phileo by Lesaffre, Milwaukee, WI) 
from d 110 of gestation until weaning.
4Nursery treatment consisted of providing a control diet or a yeast-based pre- and probiotic diet supplemented with 0.10% ActiSaf Sc 47 HR+, 0.05% SafMannan, and 0.05% NucleoSaf in phase 1 diets and 
then concentrations were lowered by 50% in phase 2 diets (Phileo by Lesaffre, Milwaukee, WI).
5The MIC numerator of the ratio was reported for the antimicrobial’s amoxicillin:clavulanic acid 2:1 ratio and trimethoprim/sulfamethoxazole.
